Abstract:Abstract Long-lived species Homo sapiens have evolved robust protection mechanisms against cancer by repressing telomerase and maintaining short telomeres, thereby delaying the onset of the majority of cancer types until post-reproductive age. Indeed, telomerase is silent in most differentiated human cells, predominantly due to the transcriptional repression of its catalytic component telomerase reverse transcriptase (TERT) gene. The lack of telomerase/TERT expression leads to progressive telomere erosion in dividing human cells, whereas critically shortened telomere length induces a permanent growth arrest stage named replicative senescence. TERT/telomerase activation has been experimentally shown to be essential to cellular immortalization and malignant transformation by stabilizing telomere length and erasing the senescence barrier. Consistently, TERT expression/telomerase activity is detectable in up to 90% of human primary cancers. Compelling evidence has also accumulated that TERT contributes to cancer development and progression via multiple activities beyond its canonical telomere-lengthening function. Given these key roles of telomerase and TERT in oncogenesis, great efforts have been made to decipher mechanisms underlying telomerase activation and TERT induction. In the last two decades since the TERT gene and promoter were cloned, the derepression of the TERT gene has been shown to be achieved typically at a transcriptional level through dysregulation of oncogenic factors or signaling, post-transcriptional/translational regulation and genomic amplification. However, advances in high-throughput next-generation sequencing technologies have prompted a revolution in cancer genomics, which leads to the recent discovery that genomic alterations take center stage in activating the TERT gene. In this review article, we summarize critical mechanisms activating TERT transcription, with special emphases on the contribution of TERT promoter mutations and structural alterations at the TERT locus, and briefly discuss the underlying implications of these genomic events-driven TERT hyperactivity in cancer initiation/progression and potential clinical applications as well.

Research Progress of Non-telomeric Functions of Telomerase

Role of TERRA in the Regulation of Telomere Length

The telomere-independent function of telomerase

Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer

Progress in the Study of Telomere and Telomerase

Research progress on anticancer therapeutics targeting telomere/telomerase

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications

Structure, Function and Application of Telomere and Telomerase

Telomere and Telomerase Therapeutics in Cancer

Regulation of telomerase towards tumor therapy

Regulation Of Telomerase Activity By Apparently Opposing Elements

Clinical research progress of telomerase targeted cancer immunotherapy: a literature review

Therapeutic Strategies for Targeting Telomerase in Cancer

Research Progress of Small-Molecule Drugs in Targeting Telomerase in Human Cancer and Aging

The Role of Non-Coding RNA in Tumorigenesis, Development,diagnosis and Treatment

Noncanonical functions of telomerase and telomeres in viruses‐associated cancer

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players

Tumor therapy targeting human telomerase reverse transcriptase

The Discovery and Research Advances of a Telomeric Repeat-Containing Non-Coding RNA

Recent research on monitoring telomerase activity

Telomeres and telomerase of structure and regulation